AbstractObjectivesThis aim of this study is to compare the reflux esophagitis improvement effects of Sepiae Os, Arcae Concha, Ostreae Concha, and Proton Pump Inhibitor(esomeprazole) through rat experiments.
MethodsNO production inhibitory effect was measured by NO production amount and iNOS mRNA expression level in cell lines. iNOS, TNF-α and p-IκB, and serotonin were compared using immunohistochemistry at the rat reflux esophagitis. Reflux esophagitis connection external form, lower esophageal sphincter, and gap were observed and an esophageal inflammatory indicator, IL-6 activity was also evaluated by immunohistochemistry.
ResultsNO production and iNOS mRNA expression was showed concentration dependent decrease in cell lines treated with Sepiae OS, Arcae Concha, and Ostreae Concha at the experiments of cell lines. In the suppression of iNOS and p-IκB at the rat reflux esophagitis, Sepiae Os treat group(SOT) and Ostreae Concha treat group(OCT) were more effective. In the increase of serotonin at the rat reflux esophagitis, ACT, MT and OCT were more effective. Damage of lower esophageal sphincter, and gap between esophageal keratin and mucosa were observed less at the SOT, ACT, OCT. In the suppression of IL-6 at the rat reflux esophagitis, SOT and OCT were more effective than GE and, SOT was more effective than MT significantly.
참고문헌1. National Professors of Bikye Internal Medicine. Bikye Internal Medicine. Seoul. Kunja Publisher;(2009). 96:p. 314-318.
2. Cho, YS, Choi, MG, & Jeong, JJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol, (2005). 100, 747-753.
3. Lee, D, Lee, KJ, Kim, KM, & Lim, SK. Prevalence of asymptomatic erosive esophagitis and factors associated with symptom presentation of erosive esophagitis. Scand J Gastroenterol, (2013). 48, 906-912.
4. Kim, JH, Kim, JB, Kim, SY, Kim, SE, Kim, YS, & Sung, HY, et al. Current Issues on Gastroesophageal Reflux Disease. Korean J Gastroenterol, (2014). 64, 127-128.
5. Jung, HK, Hong, SJ, Jo, YJ, Jeon, SW, Cho, YK, & Lee, KJ, et al. Updated guidelines 2012 for gastroenterol reflux disease. Korean J Gastroenterol, (2012). 60(4), 195-218.
6. National Professors of Herbology. Herbology. Seoul. Youngleem Publisher;(1998). p. 475p. 513p. 632
7. Anderson, T, Rohss, K, Bredberg, E, & Hassan-Alim, M. Pharmacokinetics and pharmacodynamics of esomeprasole, the S-isomer of omeprasole. Aliment Pharmacol Ther, (2001). 15, 1563-1569.
8. Nakamura, k, Ozawa, Y, Furuta, Y, & Miyazaki, H. Effects of sodiumpolyacrylate(PANa) on acute esophagitis by gastric juice in rats. Japan J Pharmacol, (1982). 32, 445-456.
9. Sin GT. Steps to Internal Medicine 6 Gastrodigestive Disease. Seoul. Jungdam Publisher;(2002). p. 54-55.
10. Horn, J. The proton-pump inhibitors: similarities and differences. Clinther, (2000). 22, 266-280.
11. Kin, HJ, Leem, SY, Gwak, MA, Kim, DJ, & Byeon, JS. Effects of Yijintang-gamibang on Reflux Esophagitis Induced by Pylorus and Forestomach Ligition in Rat. J of Internal Korean Medicine, (2010). 31(1), 128-141.
12. Heo JI. Protective Effects of Yijin-tang-gamib-molyeo Aqueous Extracts on Reflux Esophagitis. PhD Dissertation. Daegu: Daegu Haany University;2011.
13. Dent, J. Pharmacology of esomeprazole and comparisons with omeprazole. Aliment Pharmacol Ther, (2003). 17(suppl 1), 5-9.
14. Pharmscore. Available at: http://www.pharmscore.com/news/digestive_pharms/treatarticles/esomepr1.htmlAccessed June 21, 2016.
15. Fass, R, & Dickman, R. Non erosive reflux disease. GI Motility online, (2006). 10.1038/gimo42
16. Fauci. Harrison’s Internal Medicine. Seoul. MIP Publisher;(2010). p. 2234
17. Park, K, Gwak, MA, Kim, DJ, & Byeon, JS. Protective Effects of Yijin-tang-gamibang Aqueous Extracts on Reflux Esophagitis Mediated by Antioxidant Defense Systems. Korean J of Oriental Physiology and Pathology, (2010). 24(3), 416-425.
18. Jang, MW, & Leem, SW. Experimental Study for Effect of Banhasasim-tang on Mice with Reflux Esophagitis. J of Internal Korean Medicine, (2013). 34(4), 362-374.
19. Kim, MY, Sin, YO, Lee, JY, Lee, AR, Sin, SH, & Kwon, OJ, et al. Improving Effect of a Combined Extract of Rhei Rhizoma and Glycyrrhizae Rhizoma through Anti-oxidative Stress in Reflux Esophagitis rats. Korea J of Herbology, (2015). 30(4), 37-44.
20. Kim, DJ, & No, SS. Effect on Acute reflux Esophagitis by Evodiae Fructus Aquous Extract. Korea J of Herbology, (2012). 27(1), 51-58.
21. Lee, YJ, Park, JH, & No, SS. Effects on Rats with Reflux Esophagitis Treated with Lonicerae Flos Extract. Korean J of Oriental Physiology and Pathology, (2010). 24(6), 970-975.
22. Chinese Medicine Dictionary Publish Members. Chinese Medicine Dictionary. Seoul. Jungdam Publisher;(1997). p. 1317-1320. p. 3123-3124. p. 4722-4726.
23. Lee, NK, Yun, HI, Park, SC, Park, JI, & Jo, MH. Effects of heat-treated alumen, halloysitum rubrum and os sepiae in experimentally induced stomach ulcer in rats. J of Applied Pharmacology, (1997). 5, 246-252.
24. Kim, TG, Lee, YH, Choi, YS, Byeon, JS, & Park, SD. The Effects of ShogunJungtang-ga-younggol. morea on Gastric Ulcer. J of Internal Korean Medicine, (2001). 22(1), 13-20.
25. Patk, SM, Jo, YG, Kee, JR, Lee, YC, Kim, HJ, & Kwon, YK, et al. Inhibitory Effect of Oyster Conchioloin on Pro-inflammatory Mediator in Lipopolysaccharide;Activated Raw 264.7 Cells. Korean J of Oriental Physiology and Pathology, (2008). 22(4), 878-883.
26. Lee, YT, Choi, BT, Choi, Yh, & Kang, KH. Development of Health Assistances for Anti Stress used with Ostreae Concha. Korean J of Oriental Physiology and Pathology, (2006). 20(6), 1604-1611.
27. Itzkowitz, SH, & Yio, X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol, (2004). 287(1), G7-17.
28. Stamler, JS, Singel, DJ, & Loscalzo, J. Biochemistry of nitric oxide and its redox activated forms. Science, (1992). 258, 1898-1902.
29. De May, JG, & Vanhoutte, PM. Rolo of the intima in cholinergic and purinergic relaxation of isolated canin femoral arteries. Journal of Physiology, (1981). 316, 347-355.
30. Furchgott, RF, & Zawadzki, JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, (1980). 288, 373-376.
31. Brennan, FM, Maini, RN, & Feldmann, M. Cytokine expression in chronic inflammatory disease. Br Med Bull, (1995). 51(2), 368-84.
32. Xie, QW, Kashiwabara, Y, & Nathan, C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem, 18. 269(7), 4705-8. (1994.
33. Barnes, PJ, & Karin, MN. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. Engl J Med, 10. 336(15), 1066-71. (1997.
34. Baeuerle, PA, & Baltimore, D. NF-κB - Ten years after. Cell, (1996). 87, 13-20.
35. Seo, WG, Pae, HO, Oh, GS, Chai, KY, Yun, YG, & Kwon, TO, et al. Inhibitory effect of ethyl acetate fraction from Cudrania tricuspidata on the expression of nitric oxide synthase gene in RAW 264.7 macrophages stimulated with interferon-and lipopolysaccharide. Gen Pharmacol, (2000). 35, 21-28.
36. Seo, WG, Pae, HO, Oh, GS, Chai, KY, Kwon, TO, & Yun, YG, et al. Inhibitory effects of methanol extracts of Cyrerus rotundus rhizomes on nitric oxide and superoxide production by murine macrophages cell line, RAW 264.7 cells. J Ethnopharmacol, (2001). 76, 59-64.
37. Lee, BG, Kim, SH, Zee, OP, Lee, KR, Lee, HY, & Han, JW, et al. Suppression of inducible nitric oxide synthase expression in RAW 264.7 macrophagesby two-carboline alkaloids extractes from Melia azedarach. Eur J Pharmacol, (2000). 406, 301-309.
38. Lee, DA, Lee, JR, Kim, YW, Kwon, YK, Byun, SH, & Sin, SW, et al. Inhibition of Lipopolysaccharide-Inducible Nitric Oxide Synthase, TNF-α, IL-1β and COX-2 Expression by Flower and Whole Plant of Lonicera japonica. Korean J of Oriental Physiology and Pathology, (2005). 19(2), 481-489.
39. Byeon, SH, Yang, JH, & Kim, SC. Inhibitory effect of Scrophulariae Radix extract on TNF-a, IL-1β, IL-6 and Nitric Oxide production in Lipopolysaccharide - activated Raw 264.7 cells. Korea J of Herbology, (2005). 20(2), 7-16.
40. Racke, K, Riemann, A, Schworer, H, & Kilbinger, H. Regulation of 5-HT release from enterochromaffin cell. Behav Brain Res, (1996). 73, 83-7.
41. Morrow JD, Roberts LJ. Lipid-derived autocoides, eicosanoids and platelets-activating factor. Hardman JG, Limberd LE, editors. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. USA. McGraw Hill and Co;(2001). p. 673
42. Saegusa, Y, Takeda, H, Muto, S, Oridate, N, Nakagawa, K, & Sadakane, C, et al. Decreased motility of the lower esophageal sphincter in a rat model of gastroesophageal reflux disease may be mediated by reductions of serotonin and acetylcholine signaling. Biol Pharm Bull, (2011). 34(5), 704-11.
43. Tobey, NA, Carson, JL, Alkiek, RA, & Orlando, RC. Dilated intercellular spaces: a morphlogical feature of acid reflux – damaged human esophageal epithelium. Gastroenterology, (1996). 111(5), 1200-5.
44. De Hertogh, G, Ectors, N, Van Eyken, P, & Geboes, K. Review article: the nature of oesophageal injury in gastro-oesophageal reflux disease. Aliment Pharmacol Ther, (2006). 24(Suppl2), 17-26.
45. Ardizzone, S, & Bianchi Porro, G. Biologic therapy for inflammatory bowel disease. Drugs, (2005). 65(16), 2253-86.
46. Stamler, JS, Singel, DJ, & Loscalzo, J. Biochemistry of nitric oxide and its redox activated forms. Science, (1992). 258, 1898-1902.
47. De May, JG, & Vanhoutte, PM. Rolo of the intima in cholinergic and purinergic relaxation of isolated canin femoral arteries. Journal of Physiology, (1981). 316, 347-355.
48. Furchgott, RF, & Zawadzki, JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, (1980). 288, 373-376.
49. Han, GJ, Leem, JT, Kim, JS, & Lee, JH. Analysis of the Existing Guidelines and Clinical Trials for the Development of the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease(GERD). J of Internal Korean Medicine, (2016). 37(1), 90-108.
|
|